This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Blume KG, Forman SJ, O'Donnel MR et al. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies Blood 1987 69: 1015–1020
Blume KG, Long GD, Negrin RS et al. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation Bone Marrow Transplant 1994 14: (Suppl. 4) S9-S10
Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group Blood 1995 85: 1391–1395
Bostrom B, Weisdorf DJ, Kim T et al. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide Bone Marrow Transplant 1990 5: 83–89
Giralt SA, Le Maistre CF, Vriesendorp HM et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies J Clin Oncol 1994 12: 1923–1930
Cole CH, Pritchard S, Rogers PCJ et al. Intensive conditioning regimen for bone marrow transplantation in children with high-risk haematological malignancies Med Pediatr Oncol 1994 23: 464–469
Horstmann M, Kroschke G, Stockschlader M et al. Earlytoxicity of intensified conditioning with etoposide combinedwith total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation Pediatr Hematol Oncol 1996 13: 45–53
Kroger N, Kruger W, Wacker-Backhaus G et al. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia Bone Marrow Transplant 1998 22: 1029–1033
Pirich L, Haut P, Morgan E et al. Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphoblastic leukemia Med Pediatr Oncol 1999 32: 1–6
Duerst RE, Horan JT, Liesveld JL et al. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide Bone Marrow Transplant 2000 25: 489–494
Rambaldi A, Borleri G, Dotti G et al. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation Blood 1998 91: 2189–2196
Riehm H, Gadner H, Henze G et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies Hematology and Blood Transfusion, part 2: Acute Leukemias Vol. 33: Springer: Berlin 1990 pp 439–450
Conter V, Aricò M, Valsecchi MG et al. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster–based intensive chemotherapy J Clin Oncol 1995 13: 2497–2502
Giona F, Testi AM, Moletti ML et al. Idarubicin plus cytosine-arabinoside (ALL R-87 protocol) in advanced acute lymphoblastic leukemia: the GIMEMA/AIEOP experience Leuk Lymphoma 1992 7: 15–19
Henze G, Fengler R, Hartmann R et al. Six-year experience with a comprehensive approach of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group Blood 1991 78: 1166–1172
Balduzzi A, Gaipa G, Bonanomi S et al. Leukemia-free circulating progenitor cells assessed by molecular methods in autologous transplantation in pediatric B-ALL in 2nd CR Blood 1998 10: (Suppl. 1) 648a (Abstr. 2675)
Uderzo C, Rondelli R, Dini G et al. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study Br J Haematol 1995 89: 790–797
Matsuyama T, Kojima S, Kato K . Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen Bone Marrow Transplant 1998 22: 21–26
Bordigoni P, Esperou H, Souillet G et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation with HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Societe Française de Greffe de Moelle study Br J Haematol 1998 102: 656–665
Zecca M, Pession A, Messina C et al. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings J Clin Oncol 1999 17: 1838–1846
Bacigalupo A, van Lint MT, Occhini D et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia Blood 1991 77: 1423–1428
Locatelli F, Zecca M, Rondelli R et al. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of arandomized trial Blood 2000 95: 1572–1579
Klingebiel T, Henze G, Ebell W et al. Bone marrow transplantation in children for ALL in 2nd and 3rd remission with preparation by TBI and etoposide Blood 1998 92: Abstr. 4512, 351b
Acknowledgements
We would like to thank Miss Joanna Upton for her language review and linguistic consultancy, Miss Sara Vaghi for secretary support and the ‘Comitato Maria Letizia Verga per lo Studio e la Cura delle Leucemie dell'Infanzia’ for the continuous support to our research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biagi, E., Rovelli, A., Balduzzi, A. et al. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission. Bone Marrow Transplant 26, 1260–1262 (2000). https://doi.org/10.1038/sj.bmt.1702714
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702714
This article is cited by
-
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia
International Journal of Hematology (2024)
-
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation (2023)
-
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL
Bone Marrow Transplantation (2011)
-
Autologous stem cell transplantation in hematological malignancies
Springer Seminars in Immunopathology (2004)